CCS Oncology Welcomes New Doctor To Head the Cancer Risk Assessment Program

June 29, 2013 Updated Jun 29, 2013 at 12:35 PM EDT

By Mitch Simon

...

CCS Oncology Welcomes New Doctor To Head the Cancer Risk Assessment Program

June 29, 2013 Updated Jun 29, 2013 at 12:35 PM EDT

Williamsville, NY (WKBW/Release) – Dr. Laurie M. Connors joins CCS Oncology as the Program Coordinator of High Risk Cancer Screening for hereditary cancer risk assessment based on personal and family history and BRCA genetic testing.

Connors started her career in oncology at Roswell Park Cancer Institute (RPCI) in 1997 as a family nurse practitioner after she earned a Master of Science in Nursing from the State University of New York at Buffalo. During a period of fifteen years, she gained extensive experience in the medical and surgical aspects of solid tumor oncology as well as clinical genetics. As part of her nursing career at RPCI, she achieved certification as an RN First Assistant while she worked in surgery and completed a 3 month intensive course in cancer risk assessment from the City of Hope when working in genetics.

In 2012, Connors completed a doctorate in nursing practice with research focusing on decision making of high-risk women who had completed BRCA genetic testing. Her research interests include hereditary cancer risk assessment, hereditary cancer syndromes and quality care of cancer survivors.

Connors has maintained certification by the American Nursing Credentialing Center as a Family Nurse Practitioner since 1998 and is currently licensed by New York State as a RN and FNP. She is a member of the International Society of Nurses in Genetics, the Oncology Nursing Society, the Nurse Practitioner Association of Western New York and New York State and the American Academy of Nurse Practitioners.

Connors is a Clinical Assistant Professor in the School of Nursing at UB and teaches health promotion and epidemiology as well as in the family nurse practitioner program. These professional experiences will serve to benefit the current and future patients of CCS with a new program concentrating on hereditary cancer risk assessment, genetic testing, and screening plans based on individual risk levels.

For more information about Dr. Connors and CCS Oncology’s services visit ccsoncology.com.

To submit a comment on this article, your email address is required. We respect your privacy and your email will not be visible to others nor will it be added to any email lists.